Published by Precision Oncology News
Patient Care, Research
Comprehensive analysis of a rare tumor type identifies pediatric bithalamic glioma as a distinct tumor entity with potential sensitivity to a genomically-guided treatment strategy.
Research
Researchers at UC San Francisco have discovered how PGAM1 – a protein expressed at high levels in many cancers – can contribute to tumor cells’ resistance to radiation therapy and chemotherapy.
Research
Published by i3 Health News & Perspectives
Patient Care, Research
Within the next few months, the UCSF Brain Tumor Center will begin recruiting for a multi-center clinical trial to evaluate AG-881 for treatment of recurrent IDH-mutant grade II glioma.
Research
Published by UCSF News
Patient Care, Research
In 2019, the UCSF Brain Tumor Center researchers focused on therapeutic targets for glioblastoma, immunotherapies, precision medicine clinical trials and more.
Research
Immunotherapy encompasses a range of strategies aimed at making cancer cells more recognizable and vulnerable to attack by the patient’s immune system.
Campus News, Patient Care, Research
UCSF researchers recently received a Translational Team Science Award from the U.S. Department of Defense to support their research on immunotherapy for pediatric brain tumors.
Research
For many years, the classification of gliomas relied largely on the cells’ general appearance, as seen under a microscope. But in the last ten years, our understanding of glioma subtypes has expanded.
Research
The UCSF Brain Tumor Center is currently leading multiple clinical trials to investigate a new personalized medicine strategy for both adult and pediatric patients.
Patient Care, Research
UCSF researchers have discovered that STAG2 – a gene commonly mutated in several human cancers – plays an essential role in DNA replication, revealing potential mechanisms for therapeutically targeting glioblastoma.
Research
Published in UCSF News
Campus News, Research
UCSF researchers Joseph Costello, PhD, Hideho Okada, MD, PhD, and Aaron Diaz, PhD were awarded Brain Tumor Funders' Collaborative (BTFC) grants for their innovative work on immunotherapy strategies.
Campus News, Research
In 2018, the UCSF Brain Tumor Center published research on topics spanning from glioblastoma drug targets to blood test biopsies – and even space travel. See our top five research stories of the year.
Research
The research program of neurosurgeon Shawn Hervey-Jumper, MD, is deeply influenced by his patients’ struggles to understand how treatment will affect their quality of life.
Patient Care, Research
The UCSF Brain Tumor Center is one of four sites in the country testing a modified version of a poliovirus that had encouraging results against glioblastoma (GBM) in a recent phase I clinical trial.
Patient Care, Research
Published in UCSF News
Research
Published in UCSF News
Research